具有免疫相容性弹性体,对异物体反应的抗性增加
Xianchi Zhou1,2, Zhouyu Lu3, Wenzhong Cao2
1State Key Laboratory of Transvascular Implantation Devices, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P. R. China.
Nature communications
|August 30, 2024
概括
新的基于乙烯基的抗异体反应密集弹性体 (EVADE) 抵御医疗植入物中的免疫排斥. 这些材料显著减少炎症和囊形成,改善设备的寿命和性能.
科学领域:
- 生物材料科学 生物材料科学
- 免疫学 免疫学 免疫学
- 医疗设备工程 医疗设备工程
背景情况:
- 聚合物弹性体广泛用于可植入的医疗器械.
- 植入通常会触发异体反应 (FBR),导致免疫排斥和降低设备的有效性.
研究的目的:
- 开发和描述抗异体反应的新型免疫相容弹性体.
- 评估这些材料在临床前模型中的有效性,并评估它们在改善医疗器械性能方面的潜力.
主要方法:
- 合成基于乙烯基的抗FBR密集弹性体 (EVADE).
- 在动物和非人类灵长类动物模型中进行皮下植入,以评估FBR抑制 (炎症和囊形成).
- 分析与炎症相关的蛋白质表达 (S100A8/A9) 和纤维化的评估.
- 使用EVADE材料制造和测试连续皮下胰岛素输注 (CSII) 导管.
主要成果:
- 在动物中,EVADE材料有效抑制了炎症和囊形成,持续了一年多,在非人类灵长类动物中,持续了两个多月.
- 与聚二甲基西洛相比,EVADE植入显著降低了S100A8/A9蛋白表达.
- 抑制或淘汰S100A8/A9减弱纤维化,将其确定为纤维化抑制的潜在目标.
- 与商业设备相比,基于EVADE的CSII导管显示出更好的寿命和性能.
结论:
- EVADE材料为缓解可植入医疗器械中的免疫排斥提供了一个有希望的解决方案.
- 这些弹性体可以通过抵抗局部免疫反应来增强和扩展各种医疗器械的功能.
- 针对S100A8/A9是一个潜在的策略来抑制与医疗植入物相关的纤维化.
相关概念视频
01:41Affinity and Avidity
Overview
00:42Cross-reactivity
Overview
01:20Special Features of Adaptive Immunity
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:28Diversity of Antigen Receptors
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
01:26Antibody Actions
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...